Pfizer’s Growing Hematology Pipeline Matures With New Hemophilia, Sickle Cell Data

Multiple Modalities Advance Across Non-Malignant Diseases

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.